AstraZeneca has stated that it has the capacity to manufacture one billion doses of the University of Oxford’s potential COVID-19 vaccine and plans to begin supplying it in September.

The drugs giant also said it has already taken orders for at least four hundred million doses of the coronavirus jab it is developing with the university. AstraZeneca is planning to negotiate further deals on capacity to “ensure the delivery of a globally accessible vaccine”.